Literature DB >> 10721916

The role of probiotic cultures in the prevention of colon cancer.

L J Brady1, D D Gallaher, F F Busta.   

Abstract

Risk factors for colon cancer include both hereditary and environmental factors. Dietary patterns represent controllable risk factors for the development of colon cancer. Much attention has focused on decreasing colon cancer risk through increasing intake of dietary fiber; recently, this has included interest in the consumption of prebiotics and probiotics. Because factors involved in the initiation and promotion of colon cancer might be separated in time from actual tumor development, it is difficult to choose "outcomes" or "end points" that are definitive indicators of efficacy of probiotics or prebiotics. Studies that have explored the cause-effect relationship directly have used animal models. In this review, we have confined our discussion to animal studies from the last 10 years that have examined most directly the relationship between prebiotic and probiotic consumption and colon cancer development. To present the consensus of these studies first, it appears that probiotics with or without prebiotics have an inhibitory effect on the development of aberrant crypts (precancerous lesions) and tumors in animal models. The effect is not completely consistent and is small in some studies, but this may represent a dose or time effect.

Entities:  

Mesh:

Year:  2000        PMID: 10721916     DOI: 10.1093/jn/130.2.410S

Source DB:  PubMed          Journal:  J Nutr        ISSN: 0022-3166            Impact factor:   4.798


  19 in total

Review 1.  Techniques used to characterize the gut microbiota: a guide for the clinician.

Authors:  Marianne H Fraher; Paul W O'Toole; Eamonn M M Quigley
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2012-03-27       Impact factor: 46.802

Review 2.  Recent advances and remaining gaps in our knowledge of associations between gut microbiota and human health.

Authors:  Volker Mai; Peter V Draganov
Journal:  World J Gastroenterol       Date:  2009-01-07       Impact factor: 5.742

3.  Anti-inflammatory effects of bifidobacteria by inhibition of LPS-induced NF-kappaB activation.

Authors:  Christian-U Riedel; Francis Foata; David Philippe; Oskar Adolfsson; Bernhard-J Eikmanns; Stephanie Blum
Journal:  World J Gastroenterol       Date:  2006-06-21       Impact factor: 5.742

4.  Synergistic impact of Lactobacillus fermentum, Lactobacillus plantarum and vincristine on 1,2-dimethylhydrazine-induced colorectal carcinogenesis in mice.

Authors:  Devaraja Gayathri
Journal:  Exp Ther Med       Date:  2012-04-02       Impact factor: 2.447

5.  Bacteriocinogeny in experimental pigs treated with indomethacin and Escherichia coli Nissle.

Authors:  Jan Bures; David Smajs; Jaroslav Kvetina; Miroslav Förstl; Jan Smarda; Darina Kohoutova; Martin Kunes; Jiri Cyrany; Ilja Tacheci; Stanislav Rejchrt; Jirina Lesna; Viktor Vorisek; Marcela Kopacova
Journal:  World J Gastroenterol       Date:  2011-02-07       Impact factor: 5.742

Review 6.  Bacteria, inflammation, and colon cancer.

Authors:  Liying Yang; Zhiheng Pei
Journal:  World J Gastroenterol       Date:  2006-11-14       Impact factor: 5.742

7.  Lactobacillus casei BL23 regulates Treg and Th17 T-cell populations and reduces DMH-associated colorectal cancer.

Authors:  Marion Lenoir; Silvina Del Carmen; Naima G Cortes-Perez; Daniel Lozano-Ojalvo; Diego Muñoz-Provencio; Florian Chain; Philippe Langella; Alejandra de Moreno de LeBlanc; Jean Guy LeBlanc; Luis G Bermúdez-Humarán
Journal:  J Gastroenterol       Date:  2016-01-09       Impact factor: 7.527

8.  Saccharomyces boulardii inhibits EGF receptor signaling and intestinal tumor growth in Apc(min) mice.

Authors:  Xinhua Chen; Johannes Fruehauf; Jeffrey D Goldsmith; Hua Xu; Kianoosh K Katchar; Hon-Wai Koon; Dezheng Zhao; Efi G Kokkotou; Charalabos Pothoulakis; Ciarán P Kelly
Journal:  Gastroenterology       Date:  2009-05-29       Impact factor: 22.682

9.  Estimation of the potential antitumor activity of microencapsulated Lactobacillus acidophilus yogurt formulation in the attenuation of tumorigenesis in Apc(Min/+) mice.

Authors:  Aleksandra Malgorzata Urbanska; Jasmine Bhathena; Christopher Martoni; Satya Prakash
Journal:  Dig Dis Sci       Date:  2008-07-17       Impact factor: 3.199

Review 10.  Probiotics and the gastrointestinal tract: where are we in 2005?

Authors:  Irit Chermesh; Rami Eliakim
Journal:  World J Gastroenterol       Date:  2006-02-14       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.